贫血、FGF-23与骨骼的相互作用:SHIP研究健康成人结果
基于SHIP及SHIP-Trend人群队列5000余名成人,评估血红蛋白与骨质量、骨转换及FGF-23的年龄相关关联。贫血者骨质量更差、骨折风险更高、P1NP更低;血红蛋白与骨质量在≥40岁者正相关,与CTX在≥60岁者负相关;血红蛋白与FGF-23负相关,FGF-23与骨参数无直接关联。
要点
- 贫血成人骨质量更差、骨折风险更高、P1NP更低。
- 血红蛋白与骨质量在≥40岁者正相关,与CTX在≥60岁者负相关。
- 血红蛋白与FGF-23负相关,但FGF-23与骨质量或骨转换无直接关联。
核心结论
- 数据支持FGF-23与贫血之间存在密切关联,而贫血与老年人骨质量差相关。
- 未观察到FGF-23与骨参数的直接关联。
研究设计与样本
- 基于SHIP和SHIP-Trend人群队列5000余名成人受试者的数据。
- 采用足跟定量超声评估骨质量,检测血清CTX和P1NP评估骨转换。
- 贫血定义为男性血红蛋白<13 g/dL、女性<12 g/dL。
- 在852名受试者子集中检测血浆羧基末端FGF-23水平。
主要发现
- 贫血受试者骨质量更差、骨折风险更高、血清P1NP水平更低。
- 线性回归显示血红蛋白与骨质量在≥40岁受试者中呈正相关。
- 血红蛋白与CTX在≥60岁受试者中呈负相关。
- 血红蛋白与FGF-23浓度呈负相关。
- FGF-23与骨质量或骨转换无关联。
临床怎么用
- 对贫血成人应关注骨质量与骨折风险,尤其老年人群。
- 血红蛋白与FGF-23的负相关提示贫血评估中可关注FGF-23。
- FGF-23与骨参数无直接关联,不宜单独作为骨质量标志物。
局限性
- FGF-23仅在852名受试者子集中检测。
- 需要进一步研究阐明FGF-23对骨骼和红细胞生成的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Osteoporosis and anemia are among the most common diseases in the aging population with an increasing prevalence worldwide. OBJECTIVE: As the bone-derived hormone fibroblast growth factor 23 (FGF-23) was recently reported to regulate erythropoiesis, we examined age-related associations between hemoglobin levels and bone quality, bone turnover, and FGF-23 concentrations. DESIGN: We used data from more than 5000 adult subjects who participated in the population-based cohorts of the Study of Health in Pomerania (SHIP and SHIP-Trend). Bone quality was assessed by quantitative ultrasound at the heel, bone turnover by measurement of carboxy-terminal telopeptide of type I collagen (CTX), and intact amino-terminal propeptide of type I procollagen (P1NP) serum concentrations, respectively. Anemia was defined as hemoglobin <13 g/dL in men and <12 g/dL in women. Carboxy-terminal FGF-23 levels were measured in plasma in a subset of 852 subjects. RESULTS: Anemic subjects had poorer bone quality, higher fracture risk, and lower serum levels of P1NP than nonanemic individuals. Linear regression models revealed positive associations between hemoglobin and bone quality in subjects aged 40 or above and inverse associations with CTX in subjects aged 60 or above. Hemoglobin and FGF-23 concentrations were inversely associated, while FGF-23 was not related to bone quality or turnover. CONCLUSION: Our data corroborate a close link between FGF-23 and anemia, which is related to poor bone quality in elderly people. We observed no direct association of FGF-23 with bone parameters. Further studies are needed clarifying the role of FGF-23 on bone and red blood cell production.
引用
- Hannemann A, Nauck M, Völzke H, et al. Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP). J Clin Endocrinol Metab. 2021. PMID: 33034626. doi:10.1210/clinem/dgaa716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。